• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pneumonia mortality, comorbidities matter?

tetano

Editor, Senior Moderator
Pulmonology. 2019 Nov 28. pii: S2531-0437(19)30205-3. doi: 10.1016/j.pulmoe.2019.10.003. [Epub ahead of print] [h=1]Pneumonia mortality, comorbidities matter?[/h]
Hespanhol VP[SUP]1[/SUP], B?rbara C[SUP]2[/SUP].
[h=3]Author information[/h] 1 Pulmonology Department, Centro Hospitalar S. Jo?o, Alameda Hern?ni Monteiro, 4200 Porto, Portugal. Electronic address: espanholv1@gmail.com. 2 Dire??o Geral da Sa?de, Instituto da Sa?de Ambiental (ISAMB), Faculdade Medicina da Universidade de Lisboa, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.

[h=3]Abstract[/h] Pneumonia remains one of the most important causes of mortality. In Portugal, it is the first cause of respiratory death, excluding lung cancer. This is a retrospective cohort study designed to seek for explanations, identifying the characteristics of patients and measure the impact of each one of them on the risk of dying from pneumonia. We analyzed demographic and clinical data of all patients (pts) with 18 years or older with pneumonia requiring hospitalization registered on the national health service registry of mainland Portugal over 2015. A total of 36366 patients corresponding to 40696 pneumonia hospital admissions in 2015 were analyzed. Most of the patients were very old (median age 80 years). Hospital mortality for pneumonia was higher among older (30,3% pts>75 years). Pneumococcus is the more frequent bacterial isolate, reaching 41.2% of the isolates of total pneumonia cases. The frequency of pneumococcus decreases with aging; conversely, gram-negative bacteria and staphylococcus increase. Pneumococcus is more frequently identified in the winter, closely related to influenza outbreaks. Gram-negative bacteria are more prevalent during the summer months. Diabetes, obesity, COPD, and tobacco smoking are not associated with an increased risk of dying from pneumonia. Patients older than 75 years; living in a senior house; or with chronic renal disease, lung cancer, metastatic disease, mobility impairment, cachexia, dementia, cerebrovascular disease, and ischemic heart disease are at greater risk of dying from pneumonia. Comorbidities contribute decisively to the risk of dying from pneumonia in the hospital, regardless of their type or origin.
Copyright ? 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espa?a, S.L.U. All rights reserved.


[h=4]KEYWORDS:[/h] Comorbidities; Hospitalized pneumonia mortality; Risk model

PMID: 31787563 DOI: 10.1016/j.pulmoe.2019.10.003
Free full text
 
Back
Top Bottom